400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
ChiCTR-ROC-16010045
正在进行
/
/
/
2016-11-21
/
/
Allergic rhinitis
鼻敏感患者的鼻尖峰吸氣流量與睡眠質素之關係
鼻敏感患者的鼻尖峰吸氣流量與睡眠質素之關係
鼻敏感患者的鼻尖峰吸氣流量與睡眠質素之關係
单臂
其它
NA
/
Department of Otorhinolaryngology, Head and Neck Surgery, CUHK
/
60
/
1990-01-01
1990-01-01
/
1. Both genders of 18 years and over; 2. Abbreviated Mental Test>=6; 3. Ability to understand the nature, scope and possible consequences of the study; 4. Capability and willingness to comply with the requirements of the protocol.;
请登录查看1. With co-existing nasal conditions other than AR, which may affect nasal pathology (nasal polyposis, sinusitis, severe deviations of nasal septum, tumours of the nasal cavity, acute/chronic rhinosinusitis, or any underlying pathology that might affect nasal breathing or nocturnal sleep); 2. With prior nasal surgery eg. surgery performed in nasal cavity, sinuses; 3. History of known sleep disorder, central and obstructive sleep apnoea, narcolepsy, insomnia, patients requiring regular sleep medication and those hypersensitive to applied topical nasal steroids; 4. Respiratory tract infection within the past 30 days; 5. Clinically major cardiovascular, respiratory, hepatic, neurological, endocrine, immunological, or other major systemic diseases; 6. History of drug or alcohol abuse; 7. On concurrent immunosuppressive therapy or systemic steroid treatment; 8. On other medications that could affect nasal/ocular symptoms, sleep/daytime performance eg. decongestants, anti-inflammatory drugs, oral/long acting inhaled beta-agonist, sleeping pills; 9. On self-prescribed rhinitis or sleep medication; 10. Unable to perform PNIF by himself/herself.;
请登录查看The Chinese University of Hong Kong
/
浙江道尔生物科技有限公司2026-04-16
新药创始人2026-04-16
丁香园 Insight 数据库2026-04-16
2021至2023年理赔服务2026-04-16
干细胞与外泌体2026-04-16
细胞与基因治疗领域2026-04-16
北京药研汇2026-04-16
正大天晴药业集团2026-04-16
复融生物2026-04-16
先通医药2026-04-16